6533b822fe1ef96bd127d6c4
RESEARCH PRODUCT
Five-year prospective study on cardiovascular events, in patients with erectile dysfunction and hypotestosterone.
Mariaconcetta Di PiazzaAngela SansoneR IaconaVito BonomoManuela UsalaSalvatore NovoCarlo Pavonesubject
AdultMalemedicine.medical_specialtyBrachial ArteryUrologyCardiovascular event030204 cardiovascular system & hematologylcsh:RC870-923Settore MED/24 - UrologiaCardiovascular eventsCoronary artery diseaseCohort Studies03 medical and health sciences0302 clinical medicineErectile DysfunctionRisk Factorsmedicine.arteryInternal medicineSurveys and QuestionnairesmedicineHumansTestosteroneObesityProspective StudiesBrachial arteryProspective cohort studyStrokeReactive hyperemiaAgedDyslipidemiasAged 80 and overbusiness.industryPrevention030208 emergency & critical care medicineTestosterone (patch)Middle Agedlcsh:Diseases of the genitourinary system. Urologymedicine.diseasePrognosisSettore MED/11 - Malattie Dell'Apparato CardiovascolareErectile dysfunctionLogistic ModelsCardiovascular DiseasesCardiologybusinessDyslipidemiaFollow-Up Studiesdescription
Objective: Testosterone levels play a role in cardiac and vascular pathology. In the present study we investigated the prognostic significance of this hormone for cardiovascular outcome, in a 5-year follow-up. Materials and methods: Our cohort included 802 adult subjects, from 40 to 80 years. Patients were excluded if they had a past history of peripheral or coronary artery disease, and revascularization. A blood sample was drawn to valuate testosterone level, and we considered normal testosterone levels 300 ng/dl. FMD (flow mediated dilatation) of the brachial artery was assessed by measuring the increase of the brachial artery diameter during reactive hyperemia after transient forearm ischemia. B-mode longitudinal images of the brachial artery were obtained at the level of the antecubital fossa. The FMD was defined as the percentage change in the brachial artery diameter 60 s after releasing the ischemic cuff. Erectile dysfunction (ERD) was assessed by the International Index of Erectile Function-5 (IIEF-5) score questionnaire. We considered composite end points including the following major adverse cardiovascular events (MACEs) Results: Subjects with lower serum testosterone levels (n = 332) had higher prevalence of traditional cardiovascular risk factors, such as hypertension (p = 0.009), diabetes (p = 0.03), dyslipidemia (p < 0.0001), obesity (p = 0.002), and endothelial function score (p < 0.0001). AMI, death after AMI, major stroke and all clinical events were more frequent (p < 0.001) in patients with testosterone levels < 300 ng/dl. Further, by multiple logistic regression analysis we found that only dyslipidemia (p = 0,001), obesity (p = 0,007), testosterone < 300 ng/dl (p < 0,0001) and ED (p < 0,0001) were independent predictors of future events. Conclusions: A therapeutic intervention on testosterone may not only have a positive effect on the cardiovascular system but also an important role in preventing new cardiovascular events.
year | journal | country | edition | language |
---|---|---|---|---|
2017-12-31 | Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica |